Opportunistic salpingectomy (OS) is feasible but not performed in almost a quarter of patients later diagnosed with high-grade serous carcinoma (HGSC), and about 40% of patients with a first-degree ...

A retrospective single-center cohort of 128 patients associated frontline bevacizumab with longer overall survival in ...

Several factors make ovarian cancer particularly challenging to treat. This is largely because the cancer often spreads at a microscopic level within the abdomen early on, resulting in diagnosis at an ...

Additional research on novel targeted therapies may be necessary to address the unmet needs in this high-grade serous ovarian cancer population. Combining alpelisib (Piqray) with olaparib (Lynparza) ...

Scientists at The University of Texas at El Paso have found a promising new target in the fight against high-grade serous carcinoma, an aggressive form of ovarian cancer. Less than 50 percent of women ...

A Brazilian study finds that abnormal p53 expression identifies recurrence risk in non-invasive high-grade endometrial cancer ...

Nearly 40% of low-grade serous ovarian cancers have RAS alterations, which are predominately KRAS mutations. Despite low-grade serous ovarian cancer’s characterization as an epithelial ovarian cancer ...